Stock GNFT GENFIT S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News Genfit S.A. Nasdaq

Equities

GNFT

US3722791098

Market Closed - Nasdaq
Other stock markets
 02:00:00 26/06/2024 am IST 		Pre-market 06:09:46 pm
3.81 USD -3.05% Intraday chart for Genfit S.A. 3.83 +0.52%
21/06 European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher MT
20/06 European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher
MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading
MT
GENFIT: New EASL EASD EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At Risk MASH
PU
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
GL
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading
MT
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading
MT
HC Wainwright Raises Genfit SA Price Target to $13 From $11, Maintains Buy Rating
MT
Genfit S.A. Announces the Successful Corporate Milestone with U.S. FDA Accelerated Approval of Ipsen's Iqirvo for Primary Biliary Cholangitis
CI
Genfit Partner Ipsen Gets FDA Accelerated Approval for Primary Biliary Cholangitis Treatment
MT
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
GL
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
RE
US FDA approves Genfit and Ipsen's liver disease drug
RE
European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading
MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
MT
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT
GENFIT : Articles of Association updated on May 22, 2024
PU
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading
MT
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GNFT Stock
  4. GNFT Stock
  5. News Genfit S.A.